Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets.Power C.A., Furness R.B., Brawand C., Wells T.N.C.Gene 151:333-334(1994)
Cloning and characterization of the human neutrophil-activating peptide (ENA-78)
gene.Chang M.S., McNinch J., Basu R., Simonet S.J. Biol. Chem. 269:25277-25282(1994)
Characterization of the gene for human neutrophil-activating peptide 78 (ENA-78)
.Corbett M.S., Schmitt I., Riess O., Walz A.Biochem. Biophys. Res. Commun. 205:612-617(1994)
Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus.Zhang C., Thornton M.A., Kowalska M.A., Sachis B.S., Feldman M., Poncz M., McKenzie S.E., Reilly M.P.Blood 98:610-617(2001)
Novel polymorphism in ENA-78 gene.Amoli M.M., Thomson W., Hajeer A.H., Gonzalez-Gay M.A., Ollier W.E.R.Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78)
with homology to interleukin 8.Walz A., Burgener R., Car B., Baggiolini M., Kunkel S.L., Strieter R.M.J. Exp. Med. 174:1355-1362(1991)
Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.Wuyts A., Govaerts C., Struyf S., Lenaerts J.-P., Put W., Conings R., Proost P., Van Damme J.Eur. J. Biochem. 260:421-429(1999)
Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J.Nat. Biotechnol. 21:566-569(2003)
Regulation of the immune response by the interaction of chemokines and proteases.Struyf S., Proost P., Van Damme J.Adv. Immunol. 81:1-44(2003)